Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

3 Key Questions On Trump's Pharma Tariffs No Photo Available

Dylan Moroses

President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug compan... (more story)

Biotechs Rev Up To Go Public, Spurring Hope For The Sector No Photo Available

Yeji Jesse Lee

A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a b... (more story)

Doctors Hope Justices Maintain Shield Against Med Mal Suits No Photo Available

Dan McKay

A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from ... (more story)